{"denoms":[{"counts":[{"groupId":"BG000","value":"29"}],"units":"Participants"}],"groups":[{"description":"The study drugs will be administered in the following manner: Gemcitabine, at 1000 mg/m² IV infusion over 90 minutes, then Oxaliplatin, at 100 mg/m² IV infusion over 2 hours.","id":"BG000","title":"Oxaliplatin and Gemcitabine"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"16"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"13"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"11.5","value":"63.0"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"20"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"}]}],"title":"Pleural"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"}]}],"title":"Peritoneal"}],"description":"Pleural vs. Peritoneal","paramType":"NUMBER","title":"Primary Site","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"19"}]}],"title":"Epithelioid"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Sarcomatoid"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"Biphasic"}],"description":"Epithelioid vs. Sarcomatoid vs. Biphasic","paramType":"NUMBER","title":"Pathologic Subtype","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"}]}],"title":"0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"18"}]}],"title":"1 or more"}],"paramType":"NUMBER","title":"Prior chemotherapy regimens","unitOfMeasure":"participants"}]}